and used to inform the design of improved immunization strategies.
-- Articulate the human discovery trials agenda and balance vaccine
discovery and development.
-- Structure the vaccine field so that there are career paths for young
-- Prepare for results of the Thai prime-boost vaccine efficacy trial.
-- Systematically improve community engagement strategies, especially as
decisions are made around the design of the PAVE 100 vaccine trial.
-- Clearly communicate and manage expectations of prevention research
trials and results.
-- Increase support for pre-exposure prophylaxis (PrEP) research as well
as community stewardship of this promising area of research.
-- Engage in meaningful dialogue around the scaling-up of male
circumcision programs that adequately address HIV testing and
gender-specific issues in program rollout.
-- Expand community engagement with and critique of the microbicides
-- Reconsider how clinical trials infrastructure is sustained and clinical
research agendas are developed-in discussion led by developing country
The Report is being released ahead of HIV Vaccine Awareness Day, May 18th, which commemorates U.S. President Bill Clinton's call for a concerted effort to develop an AIDS vaccine within a decade. Today, it is a global observance to recognize and thank the thousands of volunteers, community members, health professionals, researchers and scientists who are working together to find a safe and effective AIDS vaccine.'/>"/>
|SOURCE AIDS Vaccine Advocacy Coalition|
Copyright©2008 PR Newswire.
All rights reserved